Dual-targeting non-viral vector based on polyethylenimine improves gene transfer efficiency

被引:12
|
作者
Li, D.
Tang, G. P.
Li, J. Z.
Kong, Y.
Huang, H. L.
Min, L. J.
Zhou, J.
Shen, F. P.
Wang, Q. Q.
Yu, H.
机构
[1] Zhejiang Univ, Inst Immunol, Hangzhou 310058, Peoples R China
[2] Zhejiang Univ, Inst Chem Biol & Pharmaceut Chem, Hangzhou 310028, Peoples R China
关键词
polyethylenimine; FGF receptors; integrins; targeting; gene transfer;
D O I
10.1163/156856207780852532
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Polyethylenimine (PEI) is the polymer most commonly used for transferring plasmids into eukaryotes, but its gene-transfer efficiency is lower compared to viral vectors. Receptors targeting PEI combined with ligands can enhance efficiency of gene transfer into the corresponding receptor-positive cells. Using the double-receptor-mediated pathway of viral infection, in this study we synthesized a novel non-viral vector based on PEI combined with two peptides recognizing FGF receptors (peptide YC25) and integrins (peptide CP9) on the cell surface. The dual targeting vector showed a physicochemical character similar to that of PEI, such as pDNA formation, particle size, zeta potential and lower toxicity. In vitro gene transfer showed that the dual-receptor targeted vector (YC25-PEI-CP9) exhibited a markedly higher transgene efficiency in cell lines with positive expression of FGF receptors and integrins, compared with single-peptide-modified PEI or unmodified PEI. In the cells with only integrin-positive expression, YC25-PEI-CP9 mediated a higher transgene expression than PEI but lower than CP9-PEI. The corresponding free peptides could inhibit the transgene efficiency of the peptide-coupled PEI. In vivo gene transfer in tumor-bearing nude mice also demonstrated that the dual-targeting vectors showed a significantly enhanced transfection efficiency in tumors with positive expression of FGF receptors and integrins. The synthesized polymer YC25-PEI-CP9 has the prospect to act as a novel kind of non-viral vector in gene therapy.
引用
收藏
页码:545 / 560
页数:16
相关论文
共 50 条
  • [31] Gene transfer and expression of a non-viral polycation-based vector in CD4+ cells
    R L Puls
    R F Minchin
    Gene Therapy, 1999, 6 : 1774 - 1778
  • [32] Predictive Modeling of Non-Viral Gene Transfer
    Schwake, Gerlinde
    Youssef, Simon
    Kuhr, Jan-Timm
    Gude, Sebastian
    David, Maria Pamela
    Mendoza, Eduardo
    Frey, Erwin
    Raedler, Joachim O.
    BIOTECHNOLOGY AND BIOENGINEERING, 2010, 105 (04) : 805 - 813
  • [33] Challenges in non-viral ocular gene transfer
    Peeters, L.
    Sanders, N. N.
    Demeester, J.
    De Smedt, S. C.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2007, 35 : 47 - 49
  • [34] Non-viral gene transfer to the vascular system
    Boeckle, S
    Ogris, M
    Pelisek, J
    Wagner, E
    JOURNAL OF VASCULAR RESEARCH, 2004, 41 (05) : 451 - 452
  • [35] Non-viral gene transfer for spine fusion
    Li, XH
    Bright, C
    Park, YS
    Tateno, K
    Sieber, A
    Kostuik, JP
    Leong, KW
    MOLECULAR THERAPY, 2003, 7 (05) : S377 - S378
  • [36] Chitosan-Graft-Polyethylenimine/DNA Nanoparticles as Novel Non-Viral Gene Delivery Vectors Targeting Osteoarthritis
    Lu, Huading
    Dai, Yuhu
    Lv, Lulu
    Zhao, Huiqing
    PLOS ONE, 2014, 9 (01):
  • [37] Squalene/polyethylenimine based non-viral vectors: synthesis and use in systems for sustained gene release
    David, Geta
    Clima, Lilia
    Calin, Manuela
    Constantinescu, Cristina Ana
    Balan-Porcarasu, Mihaela
    Uritu, Cristina Mariana
    Simionescu, Bogdan C.
    POLYMER CHEMISTRY, 2018, 9 (09) : 1072 - 1081
  • [38] A Novel Vector for Non-Viral Gene Therapy of Hemophilia A
    Maghodia, Ajay
    Liu, Tongyao
    Zakas, Philip
    Patarroyo-White, Susannah
    Drager, Douglas
    Yao, Qing
    Wilder, Samantha
    Mueller, Christian
    MOLECULAR THERAPY, 2023, 31 (04) : 469 - 469
  • [39] GENE THERAPY OF TUMOR METASTASIS BY NON-VIRAL VECTOR
    Li, Zheng
    Xiang, Juan Juan
    He, Zhi Guo
    Li, Xiao Ling
    Li, Xia Yu
    Li, Gui Yuan
    CELL BIOLOGY INTERNATIONAL, 2008, 32 (03) : S31 - S31
  • [40] IMPROVED OSTEOGENIC VECTOR FOR NON-VIRAL GENE THERAPY
    Hacobian, A. R. A.
    Posa-Markaryan, K.
    Sperger, S.
    Stainer, M.
    Hercher, D.
    Feichtinger, G. A.
    Schuh, C. M. A. P.
    Redl, H.
    EUROPEAN CELLS & MATERIALS, 2016, 31 : 191 - 204